http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MA-31568-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5af24bfbb650ae2e7ddf95747271e81
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
filingDate 2010-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d36b4ed2cdd462fb63a724ec881ad8a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50fe137c7c7bbfa0916fb2dc131ff8ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca3dd736d3349b24a05e5e344795890e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c4be650a9982308e5da9e9991ff726f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_449038a701df85ca68b6b05afdd15a15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cea9b1803bee3ecb5cb7a7cc31111d1d
publicationDate 2010-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MA-31568-B1
titleOfInvention IMIDAZOTHIAZOLE COMPOUNDS MODULATING SIRTUINS
abstract THE INVENTION CONCERNS NEW COMPOUNDS MODULATING SIRTUINS AND THEIR METHODS OF USE. THESE SIRTUIN-MODULATING COMPOUNDS MAY BE USED TO EXTEND THE LIFE OF A CELL AND TO TREAT AND / OR PREVENT A LARGE NUMBER OF DISEASES AND DISORDERS, INCLUDING, FOR EXAMPLE, DISEASES AND DISORDERS RELATED TO AGING AND STRESS, DIABETES, OBESITY, NEURODEGENERATIVE DISEASES, CARDIOVASCULAR DISEASE, BLOOD COAGULATION DISORDERS, INFLAMMATION, CANCER, AND / OR VASOMOTRIC IMPACT, AS WELL AS DISEASES OR DISORDERS WHICH MAY ENJOY MITOCHONDRIAL ACTIVITY MORE INTENSE. The invention also relates to compositions comprising a SIRTUIN-MODULATING COMPOUND, COMBINED WITH ANOTHER THERAPEUTIC AGENT.
priorityDate 2007-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53629147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411299842

Total number of triples: 34.